Impact of perioperative high mobility group box chromosomal protein 1 expression on long-term outcomes in patients with esophageal squamous cell carcinoma

J Gastroenterol Hepatol. 2020 May;35(5):788-794. doi: 10.1111/jgh.14854. Epub 2019 Oct 24.

Abstract

Background and aim: High mobility group box chromosomal protein-1 (HMGB-1) is a potential late mediator of sepsis and a possible risk factor for postoperative pulmonary complications after esophagectomy. This study aimed to determine the relationship between HMGB-1 and clinicopathological factors and long-term prognosis after esophagectomy for esophageal cancer.

Methods: We measured perioperative serum HMGB-1 levels using ELISA and HMGB-1 protein by immunohistochemistry expression in resected specimens.

Results: Postoperative serum HMGB-1 levels were significantly higher than preoperative levels. Preoperative serum HMGB-1 levels were significantly higher in patients with more intraoperative bleeding, longer intensive care unit stays, and postoperative pneumonia. Postoperative serum HMGB-1 levels were significantly higher in older patients and those with longer operation time and more intraoperative bleeding. There were significant differences in long-term outcomes according to postoperative but not preoperative serum HMGB-1 levels. Multivariate analysis demonstrated that advanced pathological stage, postoperative pulmonary complications, and higher postoperative serum HMGB-1 levels were independently associated with relapse-free survival and overall survival. Preoperative serum HMGB-1 levels were significantly higher in patients with high HMGB-1 expression than those with low HMGB-1 expression by immunohistochemistry, whereas such statistical differences were not observed in postoperative serum HMGB-1. There were no differences in relapse-free survival and overall survival according to HMGB-1 expression by immunohistochemistry. Serum HMGB-1 levels were significantly increased after esophagectomy for esophageal cancer.

Conclusion: Elevated postoperative serum HMGB-1, which was associated not only with poor long-term but also short-term outcomes such as postoperative complications, might serve as a potential marker for prognosis in esophageal cancer.

Keywords: cytokine production; esophagectomy; high mobility group box chromosomal protein 1; pulmonary complication; surgical stress; systemic inflammatory response syndrome.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Biosimilar Pharmaceuticals
  • Esophageal Neoplasms / diagnosis*
  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / surgery
  • Esophageal Squamous Cell Carcinoma / diagnosis*
  • Esophageal Squamous Cell Carcinoma / genetics*
  • Esophageal Squamous Cell Carcinoma / surgery
  • Esophagectomy
  • Female
  • Gene Expression*
  • HMGB1 Protein / blood*
  • HMGB1 Protein / genetics*
  • Humans
  • Male
  • Perioperative Period
  • Postoperative Complications / diagnosis
  • Postoperative Period
  • Prognosis
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Biosimilar Pharmaceuticals
  • HMGB1 Protein